Ada has spent years of fundamental research and development in new reasoning techniques, culminating in an intelligent, visual reasoning tool that sits at the interface between patients and medical professionals, and benefits both. It is supported by a comprehensive medical knowledge base, curated by Ada’s team of medical experts over six years, and today covers hundreds of thousands of real medical cases, conditions, symptoms and findings. Ada’s reasoning technology reviews multiple pieces of data to arrive at the most probable health conditions, and because it incorporates a process of multiple feedback loops and continuous learning, it continues to grow more intelligent with every interaction.
Ada’s 2020 Research team has also successfully helped integrate new data sources and pathophysiological information, including sensors, Apple Healthkit, transient manifestations of diseases, rare disease information and 23andMe into Ada’s reasoning engine. These enhancements contribute to improving the accuracy and personalisation of Ada’s health assessment, and have contributed important insights for the team’s research collaborations with the Hannover Medical School (MHH) Center for Rare Diseases and the HighMed Consortium.
In 2016, Ada translated its existing technology and medical content into a patient-facing, conversational chat bot, available to everyone in the world, and launched additional telemedicine services enabling patients to receive medical advice from doctors. There are many opportunities in the healthcare industry for Ada to grow. Since Ada launched its full end-to-end platform of services, the team has received interest from a number of governments, health providers and other industry stakeholders, where there is a lot of potential for Ada to add value.
The Ada2020 team has been actively communicating the project and its results through press interviews and digital channels- a website that carefully explains the project’s research and technology, a blog highlighting Ada team members, product updates and issues related to Ada’s global impact, and active social media channels. The Ada2020 Research team continues to work closely with stakeholders across Europe’s academic and digital health ecosystem, sharing results and new findings in publications and at health and medical conferences, among other channels.
